Method for producing hydroxythienoimidazole derivatives, vinyl sulfide derivatives, n-butylene sulfide derivatives, and saturated straight-chain hydrocarbon-substituted thienoimidazole derivatives

By performing the addition reaction between sulfolide derivatives and Grignard reagents in the presence of copper salts, the problem of low manufacturing efficiency of compounds such as hydroxythienoimidazole derivatives in the prior art is solved, and high yield and low cost are achieved. Production avoids the use of expensive catalysts.

CN116685567BActive Publication Date: 2024-11-19TOKUYAMA CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280008852.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2021-06-11
Filing Date
2022-06-10
Publication Date
2024-11-19
Estimated Expiration
2042-06-10

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently manufacture hydroxythienoimidazole derivatives, vinyl sulfide derivatives, n-butylene sulfide derivatives and saturated linear hydrocarbon-substituted thienoimidazole derivatives, and it requires the use of expensive catalysts and high temperature and high pressure conditions.

Method used

By adding the sulfide derivative with Grignard reagent in the presence of copper salt, a hydroxythienoimidazole derivative was obtained, and a vinyl sulfide derivative and a n-butyl sulfide derivative were obtained through dehydration reaction, using a low temperature short Time conditions, avoid the use of expensive catalysts.

Benefits of technology

High yield manufacturing of these compounds is achieved, reducing production costs and energy consumption, improving efficiency, and eliminating expensive catalysts such as palladium catalysts are not required.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004313796240000011
    Figure BDA0004313796240000011
  • Figure BDA0004313796240000021
    Figure BDA0004313796240000021
  • Figure BDA0004313796240000031
    Figure BDA0004313796240000031
Patent Text Reader

Abstract

The present invention aims to provide a method for producing a hydroxythienoimidazole derivative, a vinyl sulfide derivative, an n-butylene sulfide derivative, and a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative in high yield. In order to solve this problem, the production method according to one embodiment comprises the step of mixing a thiolactone derivative represented by formula (I) and a Grignard reagent represented by formula (1) or (2) in the presence of a copper salt to obtain a hydroxythienoimidazole derivative represented by formula (II) or (IV).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to a method for producing a hydroxythienoimidazole derivative, a vinyl sulfide derivative, an n-butylidene sulfide derivative, and a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative. Background Art

[0002] Biotin shown below is considered to be a type of vitamin useful as animal feed and medicine.

[0003] [Chemical formula 1]

[0004]

[0005] Non-patent document 1 describes a method for synthesizing biotin using a Grignard reagent ClMg(CH2)3OMe. Specifically, as shown below, it describes: a thiolactone compound (A) is subjected to an addition reaction with the above-mentioned Grignard reagent, the product is then hydrolyzed, the intermediate (B) thus obtained is dehydrated to obtain a compound (C), and then the compound (C) is hydrogenated to obtain a compound (D), and finally the compound (D) is subjected to coupling with a malonic ester and deprotection to obtain biotin. It should be noted that "Bn" represents a benzyl group and "Me" represents a methyl group.

[0006] [Chemical formula 2]

[0007]

[0008] Prior art literature

[0009] Non-patent literature

[0010] Non-patent literature 1: M. Gerecke, J.-P. Zimmermann, W. Aschwanden, "116.Versuche zurBiotinsynthese.Herstellung von (3aS, 6aR)-1,3-Di benzyl-tetrahydro-4H-thieno[3,4-d]imidazol-2,4(1H)-dion" Helv.Chi m.Acta.1970,53,991-999. Summary of the invention

[0011] Problems to be solved by the invention

[0012] An object of the present invention is to provide a method for producing a hydroxythienoimidazole derivative, a vinyl sulfide derivative, an n-butylidene sulfide derivative, and a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative in high yield.

[0013] Means for solving problems

[0014] According to one embodiment, a method for producing a hydroxythienoimidazole derivative represented by the following formula (II) is provided. The method comprises mixing a thiolactone derivative represented by the following formula (I), a Grignard reagent represented by the following formula (1), and a copper salt to obtain a hydroxythienoimidazole derivative represented by the following formula (II).

[0015] [Chemical formula 3]

[0016]

[0017] In formula (I), R 1 and R 2 Each is independently an alkyl group, an alkyl group having a substituent, an aryl group, or an aryl group having a substituent.

[0018] [Chemical formula 4]

[0019]

[0020] In formula (1), R 3 X is an alkyl group, an alkyl group having a substituent, an aryl group, or an aryl group having a substituent. 1 A halogen atom.

[0021] [Chemical formula 5]

[0022]

[0023] In formula (II), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0024] According to another embodiment, a method for producing a hydroxythienoimidazole derivative represented by the following formula (IV) is provided. The method comprises the step of mixing the thiolactone derivative represented by the above formula (I), the Grignard reagent represented by the following formula (2), and a copper salt to obtain the hydroxythienoimidazole derivative represented by the following formula (IV).

[0025] [Chemical formula 6]

[0026]

[0027] In formula (2), X 2 are each independently a halogen atom.

[0028] [Chemical formula 7]

[0029]

[0030] In formula (IV), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning.

[0031] According to another embodiment, a method for producing a vinyl sulfide derivative represented by the following formula (III) is provided. The method comprises: a step of obtaining a hydroxythienoimidazole derivative represented by the above formula (II) by the method according to the above embodiment; and a step of dehydrating the obtained hydroxythienoimidazole derivative to obtain a vinyl sulfide derivative represented by the following formula (III).

[0032] [Chemical formula 8]

[0033]

[0034] In formula (III), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0035] According to another embodiment, a method for producing a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative represented by the following formula (VI) is provided. The method comprises: a step of obtaining a vinyl sulfide derivative represented by the above formula (III) by the method according to the above embodiment; and a step of contacting the obtained vinyl sulfide derivative with hydrogen in the presence of a catalyst to obtain a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative represented by the following formula (VI).

[0036] [Chemical formula 9]

[0037]

[0038] In formula (VI), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0039] According to another embodiment, a method for producing an n-butylene sulfide derivative represented by the following formula (V) is provided. The method comprises: a step of obtaining a hydroxythienoimidazole derivative represented by the above formula (IV) by the method according to the above embodiment; and a step of dehydrating the obtained hydroxythienoimidazole derivative to obtain an n-butylene sulfide derivative represented by the following formula (V).

[0040] [Chemical formula 10]

[0041]

[0042] In formula (V), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning.

[0043] Effects of the Invention

[0044] According to the present invention, a method for producing a hydroxythienoimidazole derivative, a vinyl sulfide derivative, an n-butylidene sulfide derivative, and a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative in high yield can be provided. DETAILED DESCRIPTION

[0045] The production method according to one embodiment comprises the step of mixing the thiolactone derivative represented by the above formula (I) and the Grignard reagent represented by the above formula (1) or (2) in the presence of a copper salt to obtain the hydroxythienoimidazole derivative represented by the above formula (II) or (IV). The hydroxythienoimidazole derivative can be used as an intermediate for the synthesis of the above biotin and biotin derivatives, for example.

[0046] According to this method, hydroxythienyl imidazole derivatives can be obtained with high yield. That is, copper (Cu) has high affinity with sulfur (S). Therefore, the Cu of copper salt is easy to coordinate with the S atom of thiolactone derivative, and the S atom site of thiolactone derivative is activated as a result. It is believed that the Grignard reagent is easy to react on the carbon atom of the carbonyl group adjacent to the S atom of thiolactone derivative. According to this manufacturing method, for example, compared with the previous method without adding copper salt, the minimum amount of Grignard reagent is used to complete the reaction at low temperature and in a short time. In addition, even if expensive catalysts such as palladium catalysts are not used, hydroxythienyl imidazole derivatives can be obtained with high yield. Therefore, biotin can be manufactured efficiently at low cost.

[0047] Hereinafter, the manufacturing method according to the embodiment will be described in detail.

[0048] <Thiolactone derivative represented by formula (I)>

[0049] The thiolactone derivative is represented by the following formula (I). The thiolactone derivative can be used as an intermediate for the above-mentioned biotin synthesis.

[0050] [Chemical formula 11]

[0051]

[0052] In formula (I), R 1 and R2 Each R is independently an alkyl group, an alkyl group having a substituent, an aryl group, or an aryl group having a substituent. 1 and R 2 They may be the same functional groups or different functional groups. 1 and R 2 Each independently is an alkyl group having a substituent, more preferably an alkyl group having a phenyl group, and further preferably a benzyl group.

[0053] R 1 or R 2 The alkyl group represented by R may be linear or branched. 1 or R 2 The number of carbon atoms of the alkyl group represented is, for example, 1 to 20, preferably 1 to 10, more preferably 1 to 8, further preferably 1 to 6, further preferably 1 to 4, further preferably 1 to 3, further preferably 1 or 2, further preferably 1.

[0054] R 1 or R 2 The alkyl group represented by may have a substituent. 1 or R 2 The alkyl group represented by may have a substituent, for example, an aryl group having 3 to 20 carbon atoms (preferably 6 to 20, more preferably 6 to 14, and further preferably 6 to 10), an alkoxy group having 1 to 6 carbon atoms (preferably 1 to 4, more preferably 1 to 3, and further preferably 1 or 2), a halogen atom, etc. The aryl group may be a monocyclic, bicyclic or tricyclic aromatic hydrocarbon ring group. The aryl group is preferably a monocyclic group having 3 to 8 members and more preferably a phenyl group. The alkoxy group may be straight-chain or branched. The halogen atom may be selected from fluorine atoms, chlorine atoms, bromine atoms and iodine atoms. As R 1 or R 2 The substituent that the alkyl group represented by is optionally substituted is preferably an aryl group having 3 to 8 carbon atoms, and more preferably a phenyl group. 1 or R 2 When the alkyl group represented by has a substituent, the number of the substituent is, for example, 1 to 5, preferably 1 to 3, more preferably 1 or 2, and further preferably 1.

[0055] R 1 or R 2 The aryl group represented by may be a monocyclic, bicyclic or tricyclic aromatic hydrocarbon ring group. 1 or R 2 The aryl group represented by is preferably a monocyclic ring having 3 or more members and 8 or less members. 1 or R2 The number of carbon atoms of the aryl group represented by is, for example, 3 to 30, preferably 3 to 20, more preferably 6 to 20, further preferably 6 to 14, further preferably 6 to 10. 1 or R 2 The aryl group represented by is preferably phenyl.

[0056] R 1 or R 2 The aryl group represented by may have a substituent. 1 or R 2 The substituents that the aryl represented by may have include, for example, an alkyl group having 1 to 6 carbon atoms (preferably 1 to 4, more preferably 1 to 3, and further preferably 1 or 2), an alkoxy group having 1 to 6 carbon atoms (preferably 1 to 4, more preferably 1 to 3, and further preferably 1 or 2), a carboxyl group, a halogen atom, and the like. The alkyl group and the alkoxy group may be straight-chain or branched. The halogen atom may be selected from a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom. R 1 or R 2 When the aryl group represented by has a substituent, the number of the substituent is, for example, 1 to 5, preferably 1 to 3, more preferably 1 or 2, and further preferably 1.

[0057] <First Grignard Reagent>

[0058] The first Grignard reagent is represented by the following formula (1).

[0059] [Chemical formula 12]

[0060]

[0061] In formula (1), R 3 is an alkyl group, an alkyl group having a substituent, an aryl group, or an aryl group having a substituent. 1 or R 2 The above descriptions regarding the alkyl group, alkyl group having a substituent, aryl group, and aryl group having a substituent also apply to R 3 As R 3 The alkyl group, alkyl group having a substituent, aryl group, and aryl group having a substituent represented by R 1 and R 2 The same groups as those mentioned in R 3 It is preferably an alkyl group having 1 to 6 carbon atoms, and more preferably a methyl group or an ethyl group.

[0062] X 1The halogen atom can be selected from a fluorine atom, a chlorine atom, a bromine atom and an iodine atom, and is preferably a chlorine atom or a bromine atom.

[0063] The first Grignard reagent can be obtained by, for example, bringing an organic halogen derivative represented by the following formula (1a) into contact with magnesium.

[0064] [Chemical formula 13]

[0065]

[0066] In the above formula (1a), R 3 and X 1 With R in formula (1) 3 and X 1 Same meaning.

[0067] As magnesium, simple substance magnesium is used. The magnesium may be in powder form or in long strip form.

[0068] The contact temperature of the organic halogen derivative represented by the formula (1a) and magnesium is, for example, 40° C. to 150° C., preferably 60° C. to 100° C. The contact time of the organic halogen derivative represented by the formula (1a) and magnesium is, for example, 10 minutes to 10 hours, preferably 1 hour to 5 hours.

[0069] The amount of the organic halogen derivative represented by the formula (1a) is, for example, 0.1 mol to 2 mol, and preferably 0.5 mol to 1.5 mol, based on 1 mol of magnesium.

[0070] The contact between the organic halogen derivative represented by the above formula (1a) and magnesium is preferably carried out in the presence of a magnesium activator. As the magnesium activator, for example, at least one selected from the group consisting of 1,2-dibromoethane, bromine, iodine, and trimethylsilyl chloride can be used. The amount of the magnesium activator relative to 1 mol of magnesium is, for example, 0.01 mol to 1.5 mol, preferably 0.2 mol to 0.8 mol.

[0071] The contact between the organic halogen derivative represented by the above formula (1a) and magnesium is preferably carried out in the presence of a first reaction solvent. As the first reaction solvent, for example, at least one selected from the group consisting of acetonitrile, propionitrile, tetrahydrofuran (THF), 2-methyl-tetrahydrofuran, 1,4-dioxane, tert-butyl methyl ether, diisopropyl ether, dimethyloxyethane, diglyme, acetone, methyl ethyl ketone, diethyl ketone, methyl acetate, ethyl acetate, butyl acetate, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, chlorobenzene, toluene, xylene, hexane and heptane can be used.

[0072] The amount of the first reaction solvent used in the production of the first Grignard reagent is, for example, 0.001 mL to 10 mL, and preferably 0.01 mL to 1 mL, relative to 1 mg of magnesium.

[0073] When the first reaction solvent is used, the first Grignard reagent is preferably prepared by the following method. First, the organic halogen derivative represented by formula (1a) is mixed with half the amount of the first reaction solvent to prepare an organic halogen derivative solution. Next, magnesium, a magnesium activator, and half the amount of the first reaction solvent are mixed to obtain a first mixture. The organic halogen derivative solution is added dropwise to the first mixture to obtain a second mixture. After the second mixture is heated to the above-mentioned contact temperature, it is stirred for the above-mentioned contact time to obtain the first Grignard reagent.

[0074] <Copper salt>

[0075] The valence of the copper atom contained in the copper salt is preferably univalent or divalent, more preferably univalent. The catalytic effect of the copper salt with a valence of univalent copper atom is excellent. As a copper salt, for example, copper chloride (I) (CuCl), copper chloride (II) (CuCl2), copper bromide (I) (CuBr), copper bromide (II) (CuBr2), copper cyanide (I) (CuCN), 3-methyl salicylic acid copper (I), mesitylene copper (I) (MesCu), isopropoxide copper (I) (iPrOCu), copper iodide (I) (CuI), copper iodide (II) (CuI2), copper acetate (I) (CuOAc), copper acetate (II) (Cu(OAc)2), copper sulfate (II) (CuSO4), copper oxide (I) (Cu2O), copper oxide (II) (CuO), copper pivalate (I) (CuOPiv), copper pivalate (II) (Cu(OPiv)2), at least one of sulfur-containing copper salts, etc. can be used. As a sulfur-containing copper salt, thiophene-2-carboxylic acid copper (I) is preferably used. Among copper salts in which the valence of the copper atom is 1, CuCl, CuI or CuBr is particularly preferred. CuCl, CuI and CuBr are particularly excellent in catalytic action.

[0076] <Method for producing hydroxythienoimidazole derivative represented by formula (II)>

[0077] The method for producing the hydroxythienoimidazole derivative represented by the formula (II) comprises the step of mixing the thiolactone derivative represented by the formula (I), a first Grignard reagent, and a copper salt.

[0078] When the thiolactone derivative represented by formula (I) is mixed with the Grignard reagent represented by formula (1) in the presence of a copper salt, an addition reaction is carried out to generate an intermediate represented by the following formula (Ia). Then, by hydrolysis of the intermediate, it is believed that the hydroxythienylimidazole derivative represented by the above formula (II) is obtained. The hydrolysis reaction can be carried out by treating with water or an acid. As an acid, for example, at least one selected from hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, formic acid, acetic acid, propionic acid, ammonium chloride, silica gel, etc. can be used.

[0079] [Chemical formula 14]

[0080]

[0081] The amount of the copper salt used is preferably 0.05 mol to 1 mol per mol of the first Grignard reagent, more preferably 0.5 mol to 0.8 mol, and even more preferably 0.6 mol to 0.72 mol per mol of the first Grignard reagent.

[0082] The amount of the copper salt used is usually 0.1 mol to 10 mol, preferably 0.5 mol to 5 mol, and more preferably 0.5 mol to 2 mol, based on 1 mol of the thiolactone derivative.

[0083] The amount of the first Grignard reagent used is usually 0.5 mol to 10 mol, preferably 1.0 mol to 5 mol, and more preferably 1.0 mol to 2.0 mol, based on 1 mol of the thiolactone derivative.

[0084] The mixing of the thiolactone derivative, the first Grignard reagent, and the copper salt can be carried out in the presence of a second reaction solvent. As the second reaction solvent, for example, at least one selected from tetrahydrofuran (THF), 2-methyl-tetrahydrofuran, 1,4-dioxane, tert-butyl methyl ether, cyclopentyl methyl ether, dimethoxyethane, diglyme, dichloromethane, toluene, xylene, hexane, heptane, etc. can be used. The second reaction solvent can be used alone or in combination of two or more and used as a mixed solvent. The second reaction solvent is preferably THF, toluene or a mixed solvent thereof.

[0085] The amount of the second reaction solvent used is, for example, 1 mL to 100 mL, and preferably 2 mL to 50 mL, based on 1 g of the thiolactone derivative.

[0086] The temperature when the thiolactone derivative, the first Grignard reagent, and the copper salt are mixed is, for example, in the range of -40°C to 100°C. The temperature when mixing is preferably in the range of -20°C to 40°C, and more preferably in the range of -10°C to 20°C. Within this temperature range, the yield of the hydroxythienoimidazole derivative tends to be further improved.

[0087] The time for mixing the thiolactone derivative, the first Grignard reagent and the copper salt is usually 0.5 to 72 hours, preferably 1 to 48 hours.

[0088] The mixing of the thiolactone derivative, the first Grignard reagent and the copper salt is preferably performed by the following method.

[0089] First, the first Grignard reagent and the copper salt are mixed to obtain an organic copper reagent. As the first Grignard reagent, the first Grignard reagent solution formed by dissolving the first Grignard reagent in the first or second reaction solvent can also be used. In addition, as the copper salt, the copper salt solution formed by dissolving the copper salt in the second reaction solvent can also be used. The mixing temperature of the first Grignard reagent and the copper salt is within the range of the mixing temperature of the above-mentioned thiolactone derivative, the first Grignard reagent, and the copper salt. The mixing time of the first Grignard reagent and the copper salt is, for example, more than 1 minute and less than 1 hour.

[0090] In the organic copper reagent, the first Grignard reagent and the copper salt are considered to form a copper complex represented by the following formula (3).

[0091] [Chemical formula 15]

[0092]

[0093] In formula (3), R 3 and X 1 With R in formula (1) 3 and X 1 Y represents an anion of a copper salt. m and n are each an integer from 1 to 3.

[0094] Next, the organocopper reagent is brought into contact with the thiolactone derivative represented by formula (I). As the thiolactone derivative represented by formula (I), a thiolactone derivative solution obtained by dissolving the thiolactone derivative in a second reaction solvent may also be used. The contact temperature of the organocopper reagent and the thiolactone derivative may be within the range of the mixing temperature of the above-mentioned thiolactone derivative, the first Grignard reagent, and the copper salt. The contact time of the organocopper reagent and the thiolactone derivative may be within the range of the mixing time of the above-mentioned thiolactone derivative, the first Grignard reagent, and the copper salt.

[0095] <Hydroxythienoimidazole derivative represented by formula (II)>

[0096] The hydroxythienoimidazole derivative is represented by the following formula (II): The hydroxythienoimidazole derivative can be used as an intermediate for the above-mentioned biotin synthesis.

[0097] [Chemical formula 16]

[0098]

[0099] In formula (II), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0100] The hydroxythienoimidazole derivative is derivatized to biotin using known methods.

[0101] For example, first, a hydroxythienoimidazole derivative represented by the formula (II) is dehydrated to obtain a vinyl sulfide derivative represented by the following formula (III).

[0102] [Chemical formula 17]

[0103]

[0104] In formula (III), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0105] As a method for dehydrating the hydroxythienoimidazole derivative, for example, an acid treatment or a heat treatment can be mentioned. The acid treatment, for example, comprises contacting the hydroxythienoimidazole derivative represented by formula (II) with an acid catalyst. As the acid catalyst, for example, sulfuric acid, hydrochloric acid, or a mixture thereof can be mentioned. The temperature of the heat treatment is, for example, -20 to 120°C, preferably 0 to 70°C. The acid treatment and the heat treatment can be combined.

[0106] Next, the vinyl sulfide derivative represented by formula (III) is hydrogenated in the presence of, for example, a Pd catalyst to obtain a compound represented by the following formula (VI). The obtained compound represented by formula (VI) is reacted with hydrogen bromide to obtain a compound represented by the following formula (VIII), and then the obtained compound is reacted with CH2(COOEt)2 to obtain a compound represented by the following formula (XI). The obtained compound is debenzylated and then treated with, for example, hydrogen bromide to obtain biotin. It should be noted that "Et" represents ethyl.

[0107] [Chemical formula 18]

[0108]

[0109] <Saturated straight-chain hydrocarbon-substituted thienoimidazole derivative represented by formula (VI)>

[0110] The saturated straight-chain hydrocarbon-substituted thienoimidazole derivative is represented by the following formula (VI): The saturated straight-chain hydrocarbon-substituted thienoimidazole derivative can be used as an intermediate for the above-mentioned biotin synthesis.

[0111] [Chemical formula 19]

[0112]

[0113] In formula (VI), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 3 With R in formula (1) 3 Same meaning.

[0114] The saturated straight-chain hydrocarbon-substituted thienoimidazole derivative can be obtained, for example, by contacting the vinyl sulfide derivative represented by formula (III) obtained by the method according to the above embodiment with hydrogen (H 2 ) in the presence of a catalyst.

[0115] As the catalyst, platinum catalysts such as platinum carbon and platinum oxide; palladium catalysts such as palladium black, palladium carbon, palladium acetate, palladium chloride, palladium oxide; nickel catalysts such as Raney nickel, cobalt catalysts such as Raney cobalt, ruthenium catalysts such as ruthenium chloride, iridium catalysts such as iridium chloride, iron catalysts such as iron powder can be used. Preferably, at least one of Raney nickel and palladium carbon can be used.

[0116] The amount of the catalyst is, for example, 0.001 to 1000 mol %, preferably 0.1 to 800 mol %, based on the vinyl sulfide derivative as a substrate.

[0117] When the vinyl sulfide derivative represented by the formula (III) is contacted with hydrogen in the presence of a catalyst, the hydrogen pressure is, for example, 1 to 150 atmospheres, and preferably 1 to 50 atmospheres.

[0118] When the vinyl sulfide derivative represented by the formula (III) is contacted with hydrogen in the presence of a catalyst, the contact temperature is, for example, 10 to 200°C, and preferably 25 to 150°C.

[0119] When the vinyl sulfide derivative represented by the formula (III) is contacted with hydrogen in the presence of a catalyst, the contact time is, for example, 0.5 to 100 hours, preferably 1 to 72 hours.

[0120] The contact of the vinyl sulfide derivative represented by formula (III) with hydrogen in the presence of a catalyst can be carried out in the presence of a solvent. As the solvent, methanol, ethanol, isopropanol, butanol, 2-butanol, ethylene glycol, 1,2-dimethoxyethane, methyl cellosolve, ethyl acetate, methyl acetate, THF, cyclopentyl methyl ether, 1,4-dioxane, acetic acid, water, or a mixed solvent thereof can be used. Methanol or a mixed solvent of methanol and water is preferably used.

[0121] The amount of the solvent used is, for example, 1 to 200 mL, preferably 3 to 100 mL, based on 1 g of the vinyl sulfide derivative as a substrate.

[0122] <Method for producing hydroxythienoimidazole derivative represented by formula (IV)>

[0123] The hydroxythienoimidazole derivative represented by formula (IV) can be produced by the same method as the method for producing the hydroxythienoimidazole derivative represented by formula (II) except that the second Grignard reagent is used instead of the first Grignard reagent.

[0124] That is, the method for producing the hydroxythienoimidazole derivative represented by the formula (IV) comprises the step of mixing the thiolactone derivative represented by the formula (I), the Grignard reagent represented by the formula (2), and a copper salt.

[0125] When the thiolactone derivative represented by formula (I) is mixed with the Grignard reagent represented by formula (2) in the presence of a copper salt, an addition reaction is carried out to generate an intermediate represented by the following formula (Ib). Then, after hydrolysis of the intermediate, it is believed that the hydroxythienylimidazole derivative represented by the above formula (IV) is obtained. The hydrolysis reaction can be carried out by treating with water or an acid. As an acid, for example, at least one selected from hydrochloric acid, sulfuric acid, phosphoric acid, methanesulfonic acid, p-toluenesulfonic acid, formic acid, acetic acid, propionic acid, ammonium chloride, silica gel, etc. can be used.

[0126] [Chemical formula 20]

[0127]

[0128] In formula (Ib), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning. 2 With X in formula (2) 2 Same meaning.

[0129] <Second Grignard Reagent>

[0130] The second Grignard reagent is represented by the following formula (2).

[0131] [Chemical formula 21]

[0132]

[0133] In formula (2), X 2 Each of X is independently a halogen atom. The halogen atom can be selected from fluorine atom, chlorine atom, bromine atom and iodine atom, preferably a chlorine atom or a bromine atom. 2 The halogen atoms may be the same type or different types.

[0134] The second Grignard reagent can be produced by the same method as the above-mentioned first Grignard reagent production method except that an organic halogen derivative represented by the following formula (2a) is used instead of the organic halogen derivative represented by the above-mentioned formula (1a).

[0135] [Chemical formula 22]

[0136]

[0137] In the above formula (2a), X 2 With X in formula (2) 2 Same meaning.

[0138] In the production of the hydroxythienoimidazole derivative represented by formula (IV), similarly to the production method of the hydroxythienoimidazole derivative represented by formula (II), it is preferred to use an organic copper reagent obtained by mixing the second Grignard reagent and a copper salt.

[0139] In the organic copper reagent, the second Grignard reagent and the copper salt are considered to form a copper complex represented by the following formula (4).

[0140] [Chemical formula 23]

[0141]

[0142] In formula (4), X 2 With X in formula (2) 2 have the same meaning. Z represents an anion of a copper salt. p and q are each an integer from 1 to 3.

[0143] The amount of the copper salt used is preferably 0.1 mol to 2 mol per mol of the second Grignard reagent, more preferably 0.5 mol to 1.5 mol, and even more preferably 0.6 mol to 1.2 mol per mol of the second Grignard reagent.

[0144] The amount of the copper salt used is usually 0.1 mol to 10 mol, preferably 0.5 mol to 5 mol, and more preferably 0.5 mol to 2 mol, based on 1 mol of the thiolactone derivative.

[0145] The amount of the second Grignard reagent used is usually 0.5 mol to 10 mol, preferably 1.0 mol to 5 mol, and more preferably 1.0 mol to 2 mol, based on 1 mol of the thiolactone derivative.

[0146] <Hydroxythienoimidazole derivative represented by formula (IV)>

[0147] The hydroxythienoimidazole derivative is represented by the following formula (IV): The hydroxythienoimidazole derivative can be used as an intermediate for the synthesis of a biotin derivative.

[0148] [Chemical formula 24]

[0149]

[0150] In formula (IV), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning.

[0151] By dehydrating the hydroxythienoimidazole derivative, an n-butylidene sulfide derivative represented by the following formula (V) is obtained. The n-butylidene sulfide derivative can be used as an intermediate for biotin synthesis.

[0152] [Chemical formula 25]

[0153]

[0154] In formula (V), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning.

[0155] As a method for dehydrating the hydroxythienoimidazole derivative, for example, an acid treatment or a heat treatment can be mentioned. The acid treatment, for example, comprises contacting the hydroxythienoimidazole derivative represented by formula (IV) with an acid catalyst. As the acid catalyst, for example, sulfuric acid, hydrochloric acid, or a mixture thereof can be mentioned. The temperature of the heat treatment is, for example, -20 to 120°C, preferably 0 to 70°C. The acid treatment and the heat treatment can be combined.

[0156] Example

[0157] <Example 1>

[0158] As shown in the following reaction formula, a compound represented by formula (III') is obtained from a compound represented by formula (I'). It should be noted that "Bn" represents a benzyl group, and "Me" represents a methyl group.

[0159] [Chemical formula 26]

[0160]

[0161] (Preparation of the first Grignard reagent)

[0162] First, the first Grignard reagent was prepared by the following method. After Mg (24.3 mg, 1.00 mmol, 2.0 equivalents) was activated by adding THF (1.00 mL) and 1,2-dibromoethane (0.05 mL), a THF (1.00 mL) solution of 1-chloro-3-methoxypropane (54.3 mg, 0.500 mmol, 1.00 equivalents) was slowly added dropwise. After all additions were completed, the mixture was stirred at 80°C for 3 hours.

[0163] (Manufacturing of Hydroxythienoimidazole Derivatives)

[0164] To a suspension of CuCl (24.8 mg, 0.250 mmol, 1.0 equivalent) in dry THF (1.50 mL), a THF solution (1.50 mL, 0.375 mmol, 1.5 equivalent) of the first Grignard reagent (0.25 M) obtained by the above method was added dropwise at 0°C for 5 minutes, and then stirred at 0°C for 10 minutes to obtain an organic copper reagent. To the organic copper reagent, a THF solution (2.00 mL) of the compound represented by formula (I') (84.6 mg, 0.250 mmol, 1.0 equivalent) was added dropwise at 0°C for 5 minutes, and then stirred at 0°C for 2 hours to obtain a reactant. The reactant was developed by thin layer chromatography (TLC) to confirm the completion of the reaction. As a developing solvent, a mixed solvent obtained by mixing ethyl acetate and n-hexane in a volume ratio of 1:1 was used. The Rf value of the compound represented by formula (II') is 0.11. It should be noted that the plate used in TLC is coated with silica gel, which acts as an acid to generate a compound represented by formula (II') through hydrolysis of the intermediate (see formula (Ia)). After adding 10% H2SO4 solution (2 mL) and toluene (5 mL) to the reactant at 0°C, the mixture was stirred at room temperature for 30 minutes to separate into an aqueous layer and an organic layer, thereby obtaining an organic layer.

[0165] In addition, the NMR result of the compound represented by formula (II') is shown below.

[0166] 1H NMR (400MHz, CDCl3, 30℃) δ7.35-7.22(m, 10H), 5.16-5.10(m, 1H), 4.86-4.78(m, 1H), 4.43(s, 1H), 4.17-3.96(m , 3H), 3.67 (dd, J=15.7, 9.3Hz, 1H), 3.61-3.32 (m, 5H), 3.04-2.77 (m, 2H), 2.38-2.31 (m, 1H), 2.01-1.67 (m, 3H).

[0167] (Manufacture of vinyl sulfide derivatives)

[0168] Next, after adding 1 drop (catalytic amount) of concentrated sulfuric acid to the organic layer, stirring was carried out at 60° C. for 1 hour to obtain a mixture. Using the same method as above, the mixture was developed by TLC. The Rf value of the compound represented by formula (III') was 0.50. The mixture was washed 3 times with 5 mL of 1M hydrochloric acid, further washed with 5 mL of saline, and then dried using Na2SO4 to obtain a residue. The residue was analyzed using NMR, and it was confirmed that it contained the compound represented by the above formula (III'). The yield was 97%. The NMR results of the compound represented by formula (III') are shown below.

[0169] 1 H NMR (400MHz, CDCl3, 30℃) δ7.36-7.27 (m, 10H), 5.51 (t, J=7.0Hz, 1H), 4.93 (d, J=15.6Hz, 1H), 4.79 (d, J=15.3Hz, 1H), 4.30 (d, J=7.7 Hz, 1H), 4.23 (d, J=15.3Hz, 1H), 4.10-4.04 (m, 2H), 3.36 (dt, J=12.9, 2.1Hz, 2H), 3.32 (s, 3H), 3.00-2.92 (m, 2H), 2.41-2.23 (m, 2H).

[0170] <Example 2>

[0171] The compound represented by formula (III') was obtained from the compound represented by formula (I') by the same method as described in Example 1, except that the amount of 1,2-dibromoethane was 0.025 mL, the amount of CuCl was 18.6 mg (0.188 mmol, 0.75 equivalent), and the amount of the THF solution of the first Grignard reagent was 1.10 mL (0.275 mmol, 1.1 equivalent). The yield of the compound represented by formula (III') was 100%.

[0172] <Example 3>

[0173] As shown in the following reaction formula, a compound represented by formula (V') is obtained from a compound represented by formula (I'). It should be noted that "Bn" represents a benzyl group.

[0174] [Chemical formula 27]

[0175]

[0176] (Preparation of the second Grignard reagent)

[0177] First, prepare the second Grignard reagent by the following method. After Mg (48.6 mg, 2.00 mmol, 4.0 equivalents) was activated by adding THF (1.00 mL) and 1,2-dibromoethane (0.05 mL, 0.58 mmol), a THF (1.00 mL) solution of 1,4-dichlorobutane (63.5 mg, 0.500 mmol, 1.00 equivalents) was slowly added dropwise. After all additions were completed, the mixture was stirred at 80°C for 3 hours.

[0178] (Manufacturing of Hydroxythienoimidazole Derivatives)

[0179] To a suspension of CuCl (27.2 mg, 0.275 mmol, 1.1 equivalent) in dry THF (2.00 mL), a THF solution (1.10 mL, 0.275 mmol, 1.1 equivalent) of the second Grignard reagent (0.25 M) obtained by the above method was added dropwise at 0°C over 5 minutes, and then stirred at 0°C for 10 minutes to obtain an organic copper reagent. To the organic copper reagent, a THF solution (2.00 mL) of the compound represented by formula (I') (84.6 mg, 0.250 mmol, 1.0 equivalent) was added dropwise at 0°C over 5 minutes, and then stirred at 0°C for 1 hour to obtain a reactant. The reactant was developed by thin layer chromatography (TLC) to confirm the completion of the reaction. As a developing solvent, a mixed solvent obtained by mixing ethyl acetate and n-hexane in a volume ratio of 1:1 was used. The Rf value of the compound represented by formula (IV') is 0.15. It should be noted that the plate used in TLC is coated with silica gel, which acts as an acid to generate a compound represented by formula (IV') through hydrolysis of the intermediate (see formula (Ib)). After adding 10% H2SO4 solution (2 mL) and toluene (5 mL) to the reactant at 0°C, stirring was continued at room temperature for 30 minutes to separate the aqueous layer from the organic layer to obtain an organic layer.

[0180] (Manufacture of vinyl sulfide derivatives)

[0181] Next, after adding 1 drop (catalytic amount) of concentrated sulfuric acid to the organic layer, stirring was carried out at 60° C. for 1 hour to obtain a mixture. Using the same method as above, the mixture was developed by TLC. The Rf value of the compound represented by formula (V') was 0.6. The mixture was washed 3 times with 5 mL of 1M hydrochloric acid, further washed with 5 mL of saline, and then dried using Na2SO4 to obtain a residue. The residue was analyzed using NMR, and it was confirmed that it contained the compound represented by the above formula (V'). The yield was 36%. The NMR results of the compound represented by formula (V') are shown below.

[0182] 1 H NMR (400MHz, CDCl3, 30℃) δ7.36-7.24 (m, 10H), 5.46 (t, J=7.2Hz, 1H), 4.97 (d, J=15.8Hz, 1H), 4.81 (d, J=15.2Hz, 1H), 4.31-4.20 (m, 2H), 4.15-4.01 (m, 2H), 3.00-2.92 (m, 2H), 2.04 (hept, J=8.0Hz, 2H), 1.39 (sext, J=7.3Hz, 1H), 1.26 (t, J=7.1Hz, 1H), 0.91 (t, J=7.3Hz, 3H).

[0183] <Example 4>

[0184] As shown in the following reaction formula, a compound represented by the following formula (III') is obtained from a compound represented by the following formula (VI'). It should be noted that "Bn" represents a benzyl group, and "Me" represents a methyl group.

[0185] [Chemical formula 28]

[0186]

[0187] Raney nickel (92.5 mass % (in water), 100 mg, 1.58 mmol, 6.7 equivalents) was quickly weighed into a glass test tube for an autoclave, and methanol (5.00 mL) was added. After adding a methanol solution (5.00 mL) of the compound represented by formula (III') (92.6 mg, 0.235 mmol, 1.0 equivalent), it was stirred at 40°C for 20 hours under a hydrogen pressure of 20 atm. The reactants were developed by thin layer chromatography (TLC) to confirm the completion of the reaction. As a developing solvent, a mixed solvent obtained by mixing ethyl acetate and n-hexane in a volume ratio of 1:1 was used. The Rf value of the compound represented by formula (VI') is 0.51. After cooling with ice, it was opened to the atmosphere and filtered through diatomaceous earth (ethyl acetate, 5 mL×4), and the Raney nickel was carefully removed without drying it. The organic layer was washed with 1M HCl aqueous solution (20 mL×3) and brine (5 mL×1), and then dried with Na2SO4. The solvent was removed by distillation to obtain a compound represented by formula (VI') in an amount of 90.8 mg and a yield of 97%. It should be noted that only a trace amount of the compound represented by formula (III') was contained. The NMR analysis results of the compound represented by formula (VI') are shown below.

[0188] 1 H NMR (400MHz, CDCl3, 30°C) δ7.34-7.24 (m, 10H), 5.10 (d, J=15.2Hz, 1H), 4.75 (d, J=15.1Hz, 1H), 4.14 (d, J=15.2Hz, 1H), 3.99-3.95 (m, 2H), 3.87 (dd, J=9.5, 5.6Hz, 1H), 3.43-3.35(m, 2H), 3.34(s, 3H), 3.335-3.25(m, 1H), 3. 17-3.11(m, 1H), 2.77-2.66(m, 1H), 1.90-1.74(m, 2H), 1.61-1.45(m, 2H); 13 C{ 1 H} NMR (100MHz, CDCl3, 30℃) δ161.1, 137.1, 137.0, 128.8, 128.80, 128.4, 127.8, 72.2, 62.7, 61.3, 58.7, 54.2, 47.9, 46.8, 34.9, 29.2, 25.6; HRMS (FAB + )m / z calcd.For C 23 H 29 N2O2S 397.1950([M+H] + )found 397.1946.

Claims

1. A method for producing a hydroxythienoimidazole derivative, the method comprising the steps of mixing a thiolactone derivative represented by the following formula (I), a Grignard reagent represented by the following formula (1), and copper (I) chloride to obtain a hydroxythienoimidazole derivative represented by the following formula (II), In formula (I), R 1 and R 2 is benzyl, In formula (1), R 3 is methyl, X 1 is a halogen atom, In formula (II), R 1 and R 2 and R in the formula (I) 1 and R 2 Same meaning, R 3 With R in the formula (1) 3 Same meaning.

2. The method for producing a hydroxythienoimidazole derivative according to claim 1, wherein In the step, the Grignard reagent represented by the formula (1) and the copper (I) chloride are mixed to form an organic copper reagent, and then the organic copper reagent is brought into contact with the thiolactone derivative represented by the formula (I) to obtain the hydroxythienoimidazole derivative represented by the formula (II).

3. The method for producing a hydroxythienoimidazole derivative according to claim 1 or 2, wherein: The amount of the copper (I) chloride is 0.6 mol or more and 0.72 mol or less relative to 1 mol of the Grignard reagent represented by the formula (1).

4. A method for producing a vinyl sulfide derivative, the method comprising: A step of obtaining the hydroxythienoimidazole derivative by the method according to any one of claims 1 to 3; and a step of dehydrating the hydroxythienoimidazole derivative to obtain a vinyl sulfide derivative represented by the following formula (III); In formula (III), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning, R 3 With R in formula (1) 3 Same meaning.

5. A method for producing a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative, the method comprising: A step of obtaining the vinyl sulfide derivative by the method according to claim 4; and A step of contacting the vinyl sulfide derivative with hydrogen in the presence of a catalyst to obtain a saturated straight-chain hydrocarbon-substituted thienoimidazole derivative represented by the following formula (VI), In formula (VI), R 1 and R 2 With R in formula (I) 1 and R 2 Same meaning, R 3 With R in formula (1) 3 Same meaning.

6. A method for producing a n-butylene sulfide derivative, the method comprising: (A) a step of mixing a thiolactone derivative represented by the following formula (I), a Grignard reagent represented by the following formula (2), and copper (I) chloride to obtain a hydroxythienoimidazole derivative represented by the following formula (IV); and (B) a step of dehydrating the hydroxythienoimidazole derivative to obtain an n-butylene sulfide derivative represented by the following formula (V), The amount of the copper (I) chloride is 0.6 mol or more and 1.2 mol or less relative to 1 mol of the Grignard reagent represented by the formula (2), In formula (I), R 1 and R 2 is benzyl, In formula (2), X 2 are each independently a halogen atom, In formula (IV), R 1 and R 2 and R in the formula (I) 1 and R 2 The same meaning, In formula (V), R 1 and R 2 and R in the formula (I) 1 and R 2 Same meaning.

7. The method for producing a hydroxythienoimidazole derivative according to claim 6, wherein In the step (A), the Grignard reagent represented by the formula (2) and the copper (I) chloride are mixed to form an organic copper reagent, and then the organic copper reagent is contacted with the thiolactone derivative represented by the formula (I) to obtain the hydroxythienoimidazole derivative represented by the formula (IV).